Dopamine regulates canine plasma beta-endorphin-immunoreactivity levels.

Area of Science:

• Neuroendocrinology
• Dopamine signaling
• Pituitary hormone secretion

Background:

• Dopamine is a key neurotransmitter and hormone.
• The pituitary gland, particularly the intermediate lobe, produces beta-endorphin.
• The regulation of beta-endorphin secretion is not fully understood.

Purpose of the Study:

• To investigate the effect of dopamine antagonists on canine plasma beta-endorphin.
• To determine the role of dopamine in regulating beta-endorphin secretion.
• To identify the source of beta-endorphin-like peptides.

Main Methods:

• Intravenous administration of domperidone and metoclopramide in dogs.
• Pretreatment with dopamine or dexamethasone.
• Sephadex G-50 chromatography to analyze plasma peptides.

Main Results:

• Domperidone and metoclopramide significantly increased plasma beta-endorphin immunoreactivity.
• Dopamine pretreatment inhibited this elevation.
• Dexamethasone pretreatment did not affect the response.
• Chromatography confirmed the response was due to beta-endorphin-like peptides.

Conclusions:

• Pituitary beta-endorphin secretion is under tonic inhibitory control by dopamine.
• The intermediate lobe of the pituitary is likely the source of dopamine-regulated beta-endorphin secretion.